TP53 and diffuse large B-cell lymphoma: Although the current literature does not pinpoint a specific molecular pathway, we propose that future research should focus on elucidating how TP53 mutations mechanistically drive WM progression and transformation into DLBCL, particularly through its roles in cell cycle regulation, DNA damage repair, and apoptosis, which may offer insights into potential therapeutic targets [31].